CHEBI:16990 - bilirubin IXα

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name bilirubin IXα
ChEBI ID CHEBI:16990
ChEBI ASCII Name bilirubin IXalpha
Definition A member of the class of biladienes that is a linear tetrapyrrole with the dipyrrole units being of both exovinyl and endovinyl type. A product of heme degradation, it is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:3099, CHEBI:13898, CHEBI:22870
Supplier Information ChemicalBook:CB8693422, eMolecules:481780, ZINC000018007499
Download Molfile XML SDF
more structures >>
Wikipedia License
Bilirubin (BR) (adopted from German, originally bili—bile—plus ruber—red—from Latin) is a red-orange compound that occurs in the normcomponent of the straw-yellow color in urine. Another breakdown product, stercobilin, causes the brown color of feces. Although bilirubin is usually found in animals rather than plants, at least one plant species, Strelitzia nicolai, is known to contain the pigment.
Read full article at Wikipedia
Formulae C33H36N4O6
C33H36N4O6
Net Charge 0
Average Mass 584.673
Monoisotopic Mass 584.26348
InChI InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-
InChIKey BPYKTIZUTYGOLE-IFADSCNNSA-N
SMILES CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(CCC(O)=O)C(C)=C(N2)\C=C2/NC(=O)C(C=C)=C2C)N1
Metabolite of Species Details
Mus musculus (NCBI:txid10090) Source: BioModels - MODEL1507180067 See: PubMed
Homo sapiens (NCBI:txid9606) See: PubMed
Roles Classification
Chemical Role(s): antioxidant
A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
View more via ChEBI Ontology
ChEBI Ontology
Outgoing bilirubin IXα (CHEBI:16990) has part 24G7 epitope (CHEBI:142163)
bilirubin IXα (CHEBI:16990) has role antioxidant (CHEBI:22586)
bilirubin IXα (CHEBI:16990) has role human metabolite (CHEBI:77746)
bilirubin IXα (CHEBI:16990) has role mouse metabolite (CHEBI:75771)
bilirubin IXα (CHEBI:16990) is a biladienes (CHEBI:36735)
bilirubin IXα (CHEBI:16990) is a dicarboxylic acid (CHEBI:35692)
bilirubin IXα (CHEBI:16990) is conjugate acid of bilirubin(2−) (CHEBI:57977)
Incoming bilirubin(2−) (CHEBI:57977) is conjugate base of bilirubin IXα (CHEBI:16990)
IUPAC Names
3,18-diethenyl-2,7,13,17-tetramethyl-1,19-dioxo-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid
bilirubin
Synonyms Sources
1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionic acid ChemIDplus
2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid ChemIDplus
2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid IUPAC
8,12-bis(2-carboxyethyl)-2,7,13,17-tetramethyl-3,18-divinylbiladiene-ac-1,19(21H,24H)-dione JCBN
Bilirubin KEGG COMPOUND
bilirubin(Z,Z) ChEBI
bilirubin-IXα ChEBI
Manual Xrefs Databases
Bilirubin Wikipedia
BILIRUBIN MetaCyc
BLR PDBeChem
C00029828 KNApSAcK
C00486 KEGG COMPOUND
HMDB0000054 HMDB
View more database links
Registry Numbers Types Sources
411033 Gmelin Registry Number Gmelin
635-65-4 CAS Registry Number ChemIDplus
74376 Reaxys Registry Number Reaxys
Citations
Woitowich NC, Halavaty AS, Waltz P, Kupitz C, Valera J, Tracy G, Gallagher KD, Claesson E, Nakane T, Pandey S, Nelson G, Tanaka R, Nango E, Mizohata E, Owada S, Tono K, Joti Y, Nugent AC, Patel H, Mapara A, Hopkins J, Duong P, Bizhga D, Kovaleva SE, St Peter R, Hernandez CN, Ozarowski WB, Roy-Chowdhuri S, Yang JH, Edlund P, Takala H, Ihalainen J, Brayshaw J, Norwood T, Poudyal I, Fromme P, Spence JCH, Moffat K, Westenhoff S, Schmidt M, Stojković EA (2018)
Structural basis for light control of cell development revealed by crystal structures of a myxobacterial phytochrome.
IUCrJ 5, 619-634 [PubMed:30224965]
[show Abstract]
Kuzdan C, Çoban AÇ, İnce Z, Can G, Türkoğlu Ü (2014)
The umbilical cord alpha-fetoprotein levels for predicting hyperbilirubinemia in term neonates.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 27, 265-269 [PubMed:23763371]
[show Abstract]
Kumagai A, Ando R, Miyatake H, Greimel P, Kobayashi T, Hirabayashi Y, Shimogori T, Miyawaki A (2013)
A bilirubin-inducible fluorescent protein from eel muscle.
Cell 153, 1602-1611 [PubMed:23768684]
[show Abstract]
Bhuiyan AR, Srinivasan SR, Chen W, Sultana A, Berenson GS (2008)
Association of serum bilirubin with pulsatile arterial function in asymptomatic young adults: the Bogalusa Heart Study.
Metabolism: clinical and experimental 57, 612-616 [PubMed:18442622]
[show Abstract]
Liu Y, Zhu B, Wang X, Luo L, Li P, Paty DW, Cynader MS (2003)
Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis.
Journal of neuroimmunology 139, 27-35 [PubMed:12799017]
[show Abstract]
Minetti M, Mallozzi C, Di Stasi AM, Pietraforte D (1998)
Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma.
Archives of biochemistry and biophysics 352, 165-174 [PubMed:9587403]
[show Abstract]
Yamaguchi T, Shioji I, Sugimoto A, Komoda Y, Nakajima H (1996)
Epitope of 24G7 anti-bilirubin monoclonal antibody.
Biochimica et biophysica acta 1289, 110-114 [PubMed:8605219]
[show Abstract]
Last Modified
06 June 2022